Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04770
Species: Homo sapiens
Position : chr17:42078767-42079095
Year: 2012
Title: Transcriptional regulation of N-acetylglutamate synthase.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
PMID:  22383952
Tissue: liver
Tissue Ontology ID: UBERON:0002107
Cell Source: Hep-G2
CVCL ID: CVCL_0027
Cell Type: epithelial cell
Cell Ontology ID: CL:0000066
Experiment Type: Enhancer activity assay;TF binding assay
Low Throughput Method: Dual-luciferase reporter assay;site-directed mutagenesis;DNA-protein pull-down;ChIP-qPCR
About Target Gene
Target gene : NAGS
About TF
TF name : NFYA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
NFYA Activation of gene expression by SREBF (SREBP) reactome 42
NFYA ATF4 activates genes reactome 25
NFYA ATF6-alpha activates chaperone genes reactome 10
NFYA Direct p53 effectors pid 141
NFYA PPARA activates gene expression reactome 113
NFYA TGF_beta_Receptor netpath 220
NFYA Validated targets of C-MYC transcriptional repression pid 63
NFYA Antigen processing and presentation kegg 75
Enhancer Associated Network
Overlapping Enhancers (hg19) 9 found
Enhancer ID Position Tissue Cell Disease
E_03068 chr17:42078635-42079129 liver hepatocyte NA
E_04769 chr17:42078767-42079095 liver epithelial cell NA
E_04785 chr17:42078767-42079095 liver epithelial cell NA
E_03116 chr17:42078768-42079095 liver hepatocyte-lineage cell hyperammonemia due to N-acetylglutamate synthase deficiency
E_03121 chr17:42078768-42079095 liver malignant cell hyperammonemia due to N-acetylglutamate synthase deficiency
E_04778 chr17:42078865-42079198 liver hepatocyte NA
E_04779 chr17:42078865-42079198 liver hepatocyte NA
E_04780 chr17:42078865-42079198 liver hepatocyte NA
E_03164 chr17:42078932-42079032 NA NA NA
Expression of Target Genes for the Enhancer